Similar articles

• The effects of lesions in the head of the caudate nucleus on spontaneous and L-DOPA induced activity in the cat.

  Harik SI, Morris PL. Harik SI, et al. Brain Res. 1973 Nov 9;62(1):279-85. doi: 10.1016/0006-8993(73)90642-2. Brain Res. 1973. PMID: 4765117 No abstract available.
• [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].

  Bergamini L, Bonzanino O, Brignolio F, Fabiani A, Fariello R, Mombelli AM, Mutani R, Pisani W, Postir A, Quattroccolo G, Riccio A, Sabbatini F, Sandigliano G, Schiffer D. Bergamini L, et al. Riv Patol Nerv Ment. 1970 Feb;91(1):62-6. Riv Patol Nerv Ment. 1970. PMID: 5524934 Italian. No abstract available.
• Reversal of the reserpine syndrome with L-dopa metabolites in reserpinized rats.

  Ericsson AD, Wertman BG, Duffy KM. Ericsson AD, et al. Neurology. 1971 Oct;21(10):1023-9. doi: 10.1212/wnl.21.10.1023. Neurology. 1971. PMID: 5165302 No abstract available.
• L-Dopa in the treatment of parkinsonism.

  Calne DB. Calne DB. Clin Pharmacol Ther. 1970 Nov-Dec;11(6):789-801. doi: 10.1002/cpt1970116789. Clin Pharmacol Ther. 1970. PMID: 4921292 Review. No abstract available.
• The pharmacology of extrapyramidal movement disorders.

  Klawans HL Jr. Klawans HL Jr. Monogr Neural Sci. 1973;2:1-136. Monogr Neural Sci. 1973. PMID: 4271860 Review. No abstract available.